Related Insights
Analysis and perspectives relevant to this provider and sector.
Ablynx was a Belgian biotechnology company developing nanobody-based therapies. It was acquired by Sanofi in 2018 and its nanobody platform continues to generate new medicines.
Ablynx was a Belgian biotechnology company developing nanobody-based therapies. It was acquired by Sanofi in 2018 and its nanobody platform continues to generate new medicines.
Analysis and perspectives relevant to this provider and sector.
